Literature DB >> 8453041

Age dependence of striatal neuronal death caused by mitochondrial dysfunction.

S R Bossi1, J R Simpson, O Isacson.   

Abstract

Several lines of evidence point to a decline in mitochondrial efficiency with age. The relationship between age and sensitivity to Huntington disease-like neuronal death in the striatum induced by the mitochondrial inhibitor 3-nitropropionic acid (3-NP) was examined. 3-NP has been shown to cause degeneration of striatum, hippocampus, and thalamus in rat and of caudate-putamen in humans. We administered single doses of 3-NP intraperitoneally to rats of various ages. Animals older than 4 months exhibited a far greater susceptibility to striatal neurotoxicity and mortality compared with younger animals. These results are discussed in the context of age-dependent metabolic impairment, which may be a key factor in the etiology of neurodegenerative disorders such as Huntington's disease and Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453041     DOI: 10.1097/00001756-199301000-00019

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

Review 1.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

2.  Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription.

Authors:  Marcus J Calkins; Rebekah J Jakel; Delinda A Johnson; Kaimin Chan; Yuet Wai Kan; Jeffrey A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

3.  Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation.

Authors:  L A Lione; R J Carter; M J Hunt; G P Bates; A J Morton; S B Dunnett
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

Review 4.  Of mice and men: solving the molecular mysteries of Huntington's disease.

Authors:  P F Shelbourne
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

5.  No spatial memory deficit exists in Kunming mice that recently recovered from motor defects following 3-nitropropionic acid intoxication.

Authors:  Xiao-Min Li; Bing-Gen Zhu; Jian-Bo Ni; Chun-Yan Cao; Jie-Ping Zhang; Xu-Dong Zhao; Rong-Shen Zhu
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203

6.  Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.

Authors:  D S Reynolds; R J Carter; A J Morton
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

7.  N-methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity.

Authors:  Payman Nasr; Timothy Carbery; James W Geddes
Journal:  Neurochem Res       Date:  2008-08-08       Impact factor: 3.996

8.  The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease.

Authors:  Faye Begeti; Adrian Y K Tan; Gemma A Cummins; Lucy M Collins; Natalie Valle Guzman; Sarah L Mason; Roger A Barker
Journal:  J Neurol       Date:  2013-08-07       Impact factor: 4.849

9.  Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients.

Authors:  Hyemyung Seo; Woori Kim; Ole Isacson
Journal:  Hum Mol Genet       Date:  2008-07-17       Impact factor: 6.150

Review 10.  Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.

Authors:  Jordi Creus-Muncunill; Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.